NUST Institutions Library Catalogue catalog › Details for: Assessment of Efficacy and Safety of COVID-19 Vaccination in Cancer Patients of Pakistan /

Normal view MARC view ISBD view

Assessment of Efficacy and Safety of COVID-19 Vaccination in Cancer Patients of Pakistan / Sadaf Ishaq

By: Ishaq, Sadaf Contributor(s): Supervisor : Dr. Adeeb Shehzad Material type: Text

TextIslamabad : SMME- NUST; 2022Description: 58p. Soft Copy 30cmSubject(s): MS Biomedical Sciences (BMS)DDC classification: 610 Online resources: Click here to access online

Tags from this library: No tags from this library for this title. Log in to add tags.

Holdings ( 1 )
Title notes ( 1 )
Comments ( 0 )

Item type	Current location	Home library	Shelving location	Call number	Status	Date due	Barcode	Item holds
Thesis	School of Mechanical & Manufacturing Engineering (SMME)	School of Mechanical & Manufacturing Engineering (SMME)	E-Books	610 (Browse shelf)	Available		SMME-TH-780

Total holds: 0

Browsing School of Mechanical & Manufacturing Engineering (SMME) shelves, Shelving location: E-Books Close shelf browser

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	610 Green Synthesized Silver Nanoparticles Enhances Anticancer Activity of HDAC Inhibitor Panobinostat /	610 Saikosaponin B2 Prevents Against BAP-induced Lungs Cancer in Mouse Model by Regulating Oxidative Stress /	610 Effectiveness of Se/ZnO NPs in enhancing antibacterial activity of resin based dental composite /	610 Assessment of Efficacy and Safety of COVID-19 Vaccination in Cancer Patients of Pakistan /	610 A Cross-Sectional Study on Post COVID-19 Vaccination Adverse Effects in the Diabetic and Non-Diabetic Population /	610 Liposomal Formulation of Lapatinib for the Treatment of Breast Cancer /	610 Effect Of Emg Based Therapy On Stroke Patient /	Next

Protection through a thorough vaccination campaign has become crucial with the
beginning of the second wave of COVID-19 infection globally, notably in Pakistan in
March-April 2021. The effectiveness of vaccines in lowering the chance of contracting
serious illnesses makes them essential weapons in the fight against COVID-19.
According to the GLOBOCAN database, approximately, 19.3 million new cases in
2020 of cancer were recorded. which made it difficult for medical practitioners to
safeguard so many "sensitive" people against COVID-19. The COVID-19 outbreak
could only be stopped after it had begun through vaccination. Around the world, there
is doubt regarding the effectiveness and safety of the current COVID-19
immunization. Investigating the adverse consequences of post-COVID-19 vaccination
is the goal of this study, in cancer and non-cancer subjects who received a range of
vaccinations, including inactivated viral vaccines (Sinopharm and Sinovac), RNAbased vaccines (Moderna and Pfizer), and non-replicating viral vaccines (AstraZeneca
and Casino bio) based on Adenovirus (Sputnik-V). In this study, questionnaires and
interviews were used to examine the concurrent side effects of various COVID-19
vaccines in populations with and without cancer. IBM-SPSS was used to analyze the
data using a chi-square test and an independent sample T-test. The non-cancer category
was where the majority of the negative effects were documented. Patients who
received the vaccine safely under the care of the medical oncology clinic reported no
significant toxicity. Concluded that these vaccines are safe for both cancer patients and
people without cancer. Based on the information available, we advise cancer patients
to get the inactivated viral-based COVID-19 vaccination

There are no comments on this title.

to post a comment.